Literature DB >> 3293971

Breast cancer. Advances in management.

G N Brodie1, A Elefanty.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3293971     DOI: 10.2165/00003495-198835050-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  45 in total

1.  Long-term effect of a first pregnancy on the secretion of prolactin.

Authors:  V C Musey; D C Collins; P I Musey; D Martino-Saltzman; J R Preedy
Journal:  N Engl J Med       Date:  1987-01-29       Impact factor: 91.245

2.  A randomized study of intensive versus moderate chemotherapy programs in metastatic breast cancer.

Authors:  D Rosner; T Nemoto; W W Lane
Journal:  Cancer       Date:  1987-03-01       Impact factor: 6.860

Review 3.  Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems.

Authors:  A Recht; J L Connolly; S J Schnitt; B Cady; S Love; R T Osteen; W B Patterson; R Shirley; W Silen; S Come
Journal:  Semin Oncol       Date:  1986-12       Impact factor: 4.929

4.  Moderate alcohol consumption and the risk of breast cancer.

Authors:  W C Willett; M J Stampfer; G A Colditz; B A Rosner; C H Hennekens; F E Speizer
Journal:  N Engl J Med       Date:  1987-05-07       Impact factor: 91.245

5.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

6.  Low-dose radiation--a cause of breast cancer?

Authors:  C E Land
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

7.  Dietary fat and the risk of breast cancer.

Authors:  W C Willett; M J Stampfer; G A Colditz; B A Rosner; C H Hennekens; F E Speizer
Journal:  N Engl J Med       Date:  1987-01-01       Impact factor: 91.245

8.  Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial.

Authors:  B Fisher; A Brown; N Wolmark; C Redmond; D L Wickerham; J Wittliff; N Dimitrov; S Legault-Poisson; H Schipper; D Prager
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

9.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  2 in total

Review 1.  Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  L M Hollingshead; D Faulds
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 2.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.